Compared to Estimates, Northrop Grumman (NOC) Q1 Earnings: A Look at Key Metrics

22.04.25 15:30 Uhr

Werte in diesem Artikel
Aktien

431,50 EUR 5,90 EUR 1,39%

Indizes

5.686,7 PKT 82,5 PKT 1,47%

Northrop Grumman (NOC) reported $9.47 billion in revenue for the quarter ended March 2025, representing a year-over-year decline of 6.6%. EPS of $6.06 for the same period compares to $6.32 a year ago.The reported revenue compares to the Zacks Consensus Estimate of $9.91 billion, representing a surprise of -4.44%. The company delivered an EPS surprise of -2.42%, with the consensus EPS estimate being $6.21.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.Here is how Northrop Grumman performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts: Sales- Mission Systems: $2.81 billion versus the six-analyst average estimate of $2.75 billion. The reported number represents a year-over-year change of +5.6%. Sales- Aeronautics Systems: $2.81 billion compared to the $3.14 billion average estimate based on six analysts. The reported number represents a change of -5.2% year over year. Sales- Intersegment eliminations: -$526 million versus the six-analyst average estimate of -$517.83 million. The reported number represents a year-over-year change of -6.4%. Sales- Space Systems: $2.57 billion compared to the $2.66 billion average estimate based on six analysts. The reported number represents a change of -29.7% year over year. Sales- Defense Systems: $1.81 billion versus the six-analyst average estimate of $1.88 billion. The reported number represents a year-over-year change of +27.8%. Operating income (loss)- Intersegment eliminations: -$72 million versus the six-analyst average estimate of -$73.35 million. Operating income (loss)- Defense Systems: $179 million versus the six-analyst average estimate of $181.90 million. Operating income (loss)- Mission Systems: $361 million compared to the $394.99 million average estimate based on six analysts. Operating income (loss)- Space Systems: $283 million versus $286.83 million estimated by six analysts on average. Operating income (loss)- Aeronautics Systems: -$183 million compared to the $301.39 million average estimate based on six analysts. Segment operating income adjustment- Unallocated corporate expenses: -$58 million versus -$63.32 million estimated by five analysts on average. Segment operating income adjustment- FAS/CAS operating adjustment: $63 million versus the four-analyst average estimate of $64.69 million. View all Key Company Metrics for Northrop Grumman here>>>Shares of Northrop Grumman have returned +7.3% over the past month versus the Zacks S&P 500 composite's -8.9% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.5 Stocks Set to DoubleEach was handpicked by a Zacks expert as the #1 favorite stock to gain +100% or more in 2024. While not all picks can be winners, previous recommendations have soared +143.0%, +175.9%, +498.3% and +673.0%.Most of the stocks in this report are flying under Wall Street radar, which provides a great opportunity to get in on the ground floor.Today, See These 5 Potential Home Runs >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Northrop Grumman Corporation (NOC): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

In eigener Sache

Übrigens: Northrop Grumman und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und als Geschenk eine Gratisaktie erhalten.

Ausgewählte Hebelprodukte auf Northrop Grumman

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Northrop Grumman

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Quelle: Zacks

Nachrichten zu Northrop Grumman Corp.

Wer­bung

Analysen zu Northrop Grumman Corp.

DatumRatingAnalyst
29.03.2018Northrop Grumman OverweightBarclays Capital
26.10.2017Northrop Grumman OutperformRBC Capital Markets
12.01.2017Northrop Grumman OutperformRBC Capital Markets
10.11.2016Northrop Grumman OverweightBarclays Capital
06.10.2016Northrop Grumman OutperformRobert W. Baird & Co. Incorporated
DatumRatingAnalyst
29.03.2018Northrop Grumman OverweightBarclays Capital
26.10.2017Northrop Grumman OutperformRBC Capital Markets
12.01.2017Northrop Grumman OutperformRBC Capital Markets
10.11.2016Northrop Grumman OverweightBarclays Capital
06.10.2016Northrop Grumman OutperformRobert W. Baird & Co. Incorporated
DatumRatingAnalyst
19.05.2016Northrop Grumman Sector PerformRBC Capital Markets
02.05.2016Northrop Grumman Equal WeightBarclays Capital
30.04.2015Northrop Grumman NeutralUBS AG
12.02.2015Northrop Grumman Equal WeightBarclays Capital
19.10.2012Northrop Grumman performOppenheimer & Co. Inc.
DatumRatingAnalyst
13.09.2012Northrop Grumman sellUBS AG
14.06.2006Update Northrop Grumman Corp.: UnderperformGoldman Sachs

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Northrop Grumman Corp. nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen